A Phase I clinical trial (NCT06123456) investigates intravenous BPC-157 for muscle injuries, while regulatory bodies flag safety concerns and potential athletic misuse. Researchers launch the first sa...
A recent pilot study highlights the safety and efficacy of intravenous BPC-157 in treating muscle and tendon tears, with potential broader clinical applications. A pilot study on intravenous BPC-157 r...
Emerging research on BPC-157 shows potential for tissue repair, while regulatory gaps fuel off-label use in sports medicine amid ongoing safety trials. As human trials begin for BPC-157, the medical c...
The first pilot study on intravenous BPC-157 in humans shows promising safety and pharmacokinetic profiles, with potential applications in muscle and tendon repair. Initial findings from the first hum...
A comparative study on Curcumae Kwangsiensis radix (CKR) from Guangxi and Yunnan reveals key bioactive compounds for blood circulation enhancement and stasis elimination. Recent research highlights th...
